2-226797205-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005544.3(IRS1):​c.1534G>C​(p.Ala512Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0189 in 1,613,794 control chromosomes in the GnomAD database, including 354 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 27 hom., cov: 33)
Exomes 𝑓: 0.020 ( 327 hom. )

Consequence

IRS1
NM_005544.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.986

Publications

31 publications found
Variant links:
Genes affected
IRS1 (HGNC:6125): (insulin receptor substrate 1) This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026758611).
BP6
Variant 2-226797205-C-G is Benign according to our data. Variant chr2-226797205-C-G is described in ClinVar as Benign. ClinVar VariationId is 522186.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0133 (2023/152332) while in subpopulation NFE AF = 0.0221 (1505/68020). AF 95% confidence interval is 0.0212. There are 27 homozygotes in GnomAd4. There are 948 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2023 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRS1NM_005544.3 linkc.1534G>C p.Ala512Pro missense_variant Exon 1 of 2 ENST00000305123.6 NP_005535.1 P35568
IRS1XM_047444223.1 linkc.1534G>C p.Ala512Pro missense_variant Exon 1 of 2 XP_047300179.1
IRS1XM_047444224.1 linkc.1534G>C p.Ala512Pro missense_variant Exon 1 of 2 XP_047300180.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRS1ENST00000305123.6 linkc.1534G>C p.Ala512Pro missense_variant Exon 1 of 2 1 NM_005544.3 ENSP00000304895.4 P35568

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2023
AN:
152214
Hom.:
27
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00323
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.00464
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00786
Gnomad FIN
AF:
0.0213
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0221
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.0140
AC:
3505
AN:
250798
AF XY:
0.0144
show subpopulations
Gnomad AFR exome
AF:
0.00353
Gnomad AMR exome
AF:
0.00463
Gnomad ASJ exome
AF:
0.00517
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0211
Gnomad NFE exome
AF:
0.0217
Gnomad OTH exome
AF:
0.0147
GnomAD4 exome
AF:
0.0195
AC:
28529
AN:
1461462
Hom.:
327
Cov.:
37
AF XY:
0.0194
AC XY:
14092
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.00278
AC:
93
AN:
33480
American (AMR)
AF:
0.00479
AC:
214
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00593
AC:
155
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00768
AC:
662
AN:
86242
European-Finnish (FIN)
AF:
0.0213
AC:
1132
AN:
53052
Middle Eastern (MID)
AF:
0.00433
AC:
25
AN:
5768
European-Non Finnish (NFE)
AF:
0.0227
AC:
25266
AN:
1111982
Other (OTH)
AF:
0.0162
AC:
981
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1677
3354
5030
6707
8384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0133
AC:
2023
AN:
152332
Hom.:
27
Cov.:
33
AF XY:
0.0127
AC XY:
948
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00322
AC:
134
AN:
41588
American (AMR)
AF:
0.00464
AC:
71
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00518
AC:
18
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.00787
AC:
38
AN:
4828
European-Finnish (FIN)
AF:
0.0213
AC:
226
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0221
AC:
1505
AN:
68020
Other (OTH)
AF:
0.0109
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
105
210
314
419
524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0194
Hom.:
10
Bravo
AF:
0.0112
TwinsUK
AF:
0.0191
AC:
71
ALSPAC
AF:
0.0192
AC:
74
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.0203
AC:
175
ExAC
AF:
0.0142
AC:
1728
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0218
EpiControl
AF:
0.0193

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Type 2 diabetes mellitus Benign:2
Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 16, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

IRS1-related disorder Benign:1
May 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
16
DANN
Benign
0.89
DEOGEN2
Benign
0.38
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.55
N
PhyloP100
0.99
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.076
Sift
Benign
0.27
T
Sift4G
Benign
0.33
T
Polyphen
0.0060
B
Vest4
0.069
MPC
0.39
ClinPred
0.0020
T
GERP RS
4.5
Varity_R
0.14
gMVP
0.45
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801276; hg19: chr2-227661921; API